fluorodeoxyglucose f18 has been researched along with irisquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, G; Tang, H; Wang, H; Wu, Q; Xu, H; Yue, Q | 1 |
| Wang, H; Xu, H; Xue, Y; Yu, W; Zhang, Y; Zhao, X | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and irisquinone
| Article | Year |
|---|---|
Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography.
Topics: Animals; Benzoquinones; Cell Proliferation; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Multimodal Imaging; Neoplasm Transplantation; Positron-Emission Tomography; Rabbits; Radiation Tolerance; Radiation-Sensitizing Agents; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Down-Regulation; Fluorodeoxyglucose F18; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Misonidazole; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Hypoxia | 2016 |